"GHO (CODE)","GHO (DISPLAY)","GHO (URL)","PUBLISHSTATE (CODE)","PUBLISHSTATE (DISPLAY)","PUBLISHSTATE (URL)","YEAR (CODE)","YEAR (DISPLAY)","YEAR (URL)","REGION (CODE)","REGION (DISPLAY)","REGION (URL)","WORLDBANKINCOMEGROUP (CODE)","WORLDBANKINCOMEGROUP (DISPLAY)","WORLDBANKINCOMEGROUP (URL)","COUNTRY (CODE)","COUNTRY (DISPLAY)","COUNTRY (URL)","Display Value","Numeric","Low","High","StdErr","StdDev","Comments"
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","2","2.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","9","9.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","18","18.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","4","4.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","23","23.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","24","24.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","29","29.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","AFG","Afghanistan","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","AGO","Angola","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","AGO","Angola","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","AGO","Angola","","30","30.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","AGO","Angola","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","AGO","Angola","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","ALB","Albania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","AND","Andorra","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_HI","High-income","","ARE","United Arab Emirates","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","ARG","Argentina","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","ARM","Armenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","ATG","Antigua and Barbuda","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","AUS","Australia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","34","34.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","AUT","Austria","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","AZE","Azerbaijan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","51","51.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","BDI","Burundi","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","BEL","Belgium","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LI","Low-income","","BFA","Burkina Faso","","17","17.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","BFA","Burkina Faso","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","BFA","Burkina Faso","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","BFA","Burkina Faso","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","BFA","Burkina Faso","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","BFA","Burkina Faso","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BGD","Bangladesh","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","BGR","Bulgaria","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_HI","High-income","","BHR","Bahrain","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","BHS","Bahamas","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","BIH","Bosnia and Herzegovina","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","BLR","Belarus","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","BLZ","Belize","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_LMI","Lower-middle-income","","BOL","Bolivia (Plurinational State of)","","38","38.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_LMI","Lower-middle-income","","BOL","Bolivia (Plurinational State of)","","44","44.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","49","49.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","BRA","Brazil","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","12","12.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","BRB","Barbados","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","BRN","Brunei Darussalam","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","BTN","Bhutan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_UMI","Upper-middle-income","","BWA","Botswana","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","CAN","Canada","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","CHE","Switzerland","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","CHL","Chile","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","CHN","China","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","COG","Congo","","9","9.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","","","","COK","Cook Islands","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","","","","COK","Cook Islands","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","","","","COK","Cook Islands","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","","","","COK","Cook Islands","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","","","","COK","Cook Islands","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","","","","COK","Cook Islands","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","","","","COK","Cook Islands","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","","","","COK","Cook Islands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","","","","COK","Cook Islands","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","","","","COK","Cook Islands","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","","","","COK","Cook Islands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","","","","COK","Cook Islands","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","","","","COK","Cook Islands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","","","","COK","Cook Islands","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","","","","COK","Cook Islands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","","","","COK","Cook Islands","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","","","","COK","Cook Islands","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","","","","COK","Cook Islands","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","","","","COK","Cook Islands","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","","","","COK","Cook Islands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","COL","Colombia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","CPV","Cabo Verde","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","CRI","Costa Rica","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","CUB","Cuba","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","CYP","Cyprus","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","CZE","Czechia","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","DEU","Germany","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","DJI","Djibouti","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","DMA","Dominica","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","DNK","Denmark","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","DOM","Dominican Republic","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","DOM","Dominican Republic","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","DZA","Algeria","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","ECU","Ecuador","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","EGY","Egypt","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","ERI","Eritrea","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","ERI","Eritrea","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","ERI","Eritrea","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","ERI","Eritrea","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","ERI","Eritrea","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","ESP","Spain","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","EST","Estonia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","ETH","Ethiopia","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","FIN","Finland","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","FIN","Finland","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","FIN","Finland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","FIN","Finland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","FJI","Fiji","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","FRA","France","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","FRA","France","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","FRA","France","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","FRA","France","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","FRA","France","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","FRA","France","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","FRA","France","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","FRA","France","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","FRA","France","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","FRA","France","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","FSM","Micronesia (Federated States of)","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","GBR","United Kingdom of Great Britain and Northern Ireland","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","8","8.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","40","40.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","GEO","Georgia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","GHA","Ghana","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","GMB","Gambia","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","GRC","Greece","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","GRD","Grenada","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","GTM","Guatemala","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","GTM","Guatemala","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","GTM","Guatemala","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","GTM","Guatemala","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","GUY","Guyana","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_LMI","Lower-middle-income","","HND","Honduras","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_LMI","Lower-middle-income","","HND","Honduras","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","HRV","Croatia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_LI","Low-income","","HTI","Haiti","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_LI","Low-income","","HTI","Haiti","","25","25.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_LI","Low-income","","HTI","Haiti","","38","38.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_LI","Low-income","","HTI","Haiti","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","HUN","Hungary","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","21","21.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","29","29.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","23","23.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","28","28.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","IDN","Indonesia","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","27","27.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","36","36.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","51","51.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","IND","India","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRN","Iran (Islamic Republic of)","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","58","58.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","IRQ","Iraq","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","ISL","Iceland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","ISR","Israel","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","ITA","Italy","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","JAM","Jamaica","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","JOR","Jordan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","JPN","Japan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","KAZ","Kazakhstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","KEN","Kenya","","28","28.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","KEN","Kenya","","32","32.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","KEN","Kenya","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","KEN","Kenya","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","KEN","Kenya","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_LMI","Lower-middle-income","","KGZ","Kyrgyzstan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KHM","Cambodia","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","21","21.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","9","9.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","KIR","Kiribati","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","KNA","Saint Kitts and Nevis","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","KOR","Republic of Korea","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_HI","High-income","","KWT","Kuwait","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","LAO","Lao People's Democratic Republic","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","LAO","Lao People's Democratic Republic","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","42","42.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","28","28.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","14","14.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","24","24.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","34","34.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBN","Lebanon","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","LBR","Liberia","","13","13.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_UMI","Upper-middle-income","","LBY","Libya","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","22","22.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","LCA","Saint Lucia","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","LKA","Sri Lanka","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","LSO","Lesotho","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","LTU","Lithuania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","LUX","Luxembourg","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","LVA","Latvia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","MAR","Morocco","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","MCO","Monaco","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","MCO","Monaco","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","MCO","Monaco","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","MCO","Monaco","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","MCO","Monaco","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","MCO","Monaco","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_LMI","Lower-middle-income","","MDA","Republic of Moldova","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","MDV","Maldives","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","MEX","Mexico","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","6","6.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","6","6.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","58","58.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","49","49.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MHL","Marshall Islands","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","MKD","North Macedonia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","MLI","Mali","","4","4.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","2","2.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","MLT","Malta","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","MMR","Myanmar","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","MNE","Montenegro","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","MNG","Mongolia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","MOZ","Mozambique","","36","36.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","MOZ","Mozambique","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","MOZ","Mozambique","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","MOZ","Mozambique","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_HI","High-income","","MUS","Mauritius","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","MWI","Malawi","","8","8.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","MWI","Malawi","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","MWI","Malawi","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","MWI","Malawi","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","MWI","Malawi","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","MYS","Malaysia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_UMI","Upper-middle-income","","NAM","Namibia","","32","32.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_UMI","Upper-middle-income","","NAM","Namibia","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_UMI","Upper-middle-income","","NAM","Namibia","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LI","Low-income","","NER","Niger","","3","3.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","NER","Niger","","16","16.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","NER","Niger","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","NER","Niger","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","NER","Niger","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","NER","Niger","","58","58.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","NGA","Nigeria","","9","9.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_LMI","Lower-middle-income","","NIC","Nicaragua","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_LMI","Lower-middle-income","","NIC","Nicaragua","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_LMI","Lower-middle-income","","NIC","Nicaragua","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","","","","NIU","Niue","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","","","","NIU","Niue","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","","","","NIU","Niue","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","","","","NIU","Niue","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","","","","NIU","Niue","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","","","","NIU","Niue","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","NLD","Netherlands","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","NOR","Norway","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","NPL","Nepal","","25","25.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","NPL","Nepal","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","NPL","Nepal","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","NPL","Nepal","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","NRU","Nauru","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","NZL","New Zealand","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_HI","High-income","","OMN","Oman","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","30","30.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","34","34.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","38","38.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","42","42.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","43","43.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","PAK","Pakistan","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","PAN","Panama","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","9","9.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","17","17.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","42","42.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","44","44.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","PER","Peru","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","19","19.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","10","10.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","51","51.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","40","40.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PHL","Philippines","","40","40.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","PLW","Palau","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","PNG","Papua New Guinea","","20","20.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","POL","Poland","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LI","Low-income","","PRK","Democratic People's Republic of Korea","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","PRT","Portugal","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","PRY","Paraguay","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_HI","High-income","","QAT","Qatar","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","ROU","Romania","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","RUS","Russian Federation","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","RWA","Rwanda","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","RWA","Rwanda","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","RWA","Rwanda","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","RWA","Rwanda","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","RWA","Rwanda","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_HI","High-income","","SAU","Saudi Arabia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","24","24.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","61","61.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","69","69.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SDN","Sudan","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","SEN","Senegal","","13","13.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","SEN","Senegal","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","SEN","Senegal","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","SEN","Senegal","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","SEN","Senegal","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","SEN","Senegal","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_HI","High-income","","SGP","Singapore","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","SLB","Solomon Islands","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","SLB","Solomon Islands","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LI","Low-income","","SLE","Sierra Leone","","60","60.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LI","Low-income","","SLE","Sierra Leone","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LI","Low-income","","SLE","Sierra Leone","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LI","Low-income","","SLE","Sierra Leone","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","SLE","Sierra Leone","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_LMI","Lower-middle-income","","SLV","El Salvador","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","SMR","San Marino","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","SRB","Serbia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","STP","Sao Tome and Principe","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","STP","Sao Tome and Principe","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","STP","Sao Tome and Principe","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","STP","Sao Tome and Principe","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","STP","Sao Tome and Principe","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","STP","Sao Tome and Principe","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","43","43.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","58","58.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","SUR","Suriname","","58","58.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","SVK","Slovakia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","SVN","Slovenia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_HI","High-income","","SWE","Sweden","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","76","76.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","70","70.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","SWZ","Eswatini","","75","75.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_HI","High-income","","SYC","Seychelles","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","71","71.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","51","51.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","49","49.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","SYR","Syrian Arab Republic","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LI","Low-income","","TGO","Togo","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_UMI","Upper-middle-income","","THA","Thailand","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_LI","Low-income","","TJK","Tajikistan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","TKM","Turkmenistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","TLS","Timor-Leste","","30","30.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","TLS","Timor-Leste","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","TLS","Timor-Leste","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","SEAR","South-East Asia","","WB_LMI","Lower-middle-income","","TLS","Timor-Leste","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TON","Tonga","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","77","77.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","80","80.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","79","79.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","TTO","Trinidad and Tobago","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LMI","Lower-middle-income","","TUN","Tunisia","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_UMI","Upper-middle-income","","TUR","Turkey","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","74","74.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","82","82.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","TUV","Tuvalu","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","TZA","United Republic of Tanzania","","29","29.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","TZA","United Republic of Tanzania","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","TZA","United Republic of Tanzania","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","TZA","United Republic of Tanzania","","67","67.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","TZA","United Republic of Tanzania","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","TZA","United Republic of Tanzania","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","68","68.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","56","56.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","57","57.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_LMI","Lower-middle-income","","UKR","Ukraine","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","URY","Uruguay","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","85","85.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","87","87.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_HI","High-income","","USA","United States of America","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","81","81.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","44","44.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","8","8.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EUR","Europe","","WB_LMI","Lower-middle-income","","UZB","Uzbekistan","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","73","73.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","88","88.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","89","89.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","91","91.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","VCT","Saint Vincent and the Grenadines","","99","99.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","6","6.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","31","31.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","38","38.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","39","39.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AMR","Americas","","WB_UMI","Upper-middle-income","","VEN","Venezuela (Bolivarian Republic of)","","13","13.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","18","18.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","97","97.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","96","96.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","98","98.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","83","83.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","86","86.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","94","94.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","95","95.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","93","93.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","90","90.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_LMI","Lower-middle-income","","VNM","Viet Nam","","92","92.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","84","84.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","6","6.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","36","36.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","14","14.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","30","30.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","72","72.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","44","44.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","42","42.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","13","13.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","WPR","Western Pacific","","WB_UMI","Upper-middle-income","","WSM","Samoa","","44","44.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","21","21.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","26","26.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","32","32.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","35","35.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","38","38.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","43","43.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","40","40.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","45","45.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","41","41.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","49","49.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","EMR","Eastern Mediterranean","","WB_LI","Low-income","","YEM","Yemen","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2000","2000","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","62","62.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2001","2001","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2002","2002","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","46","46.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2003","2003","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","52","52.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2004","2004","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","51","51.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2005","2005","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","48","48.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2006","2006","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2007","2007","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","49","49.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2008","2008","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2009","2009","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2010","2010","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2011","2011","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2012","2012","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2013","2013","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","55","55.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","59","59.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","53","53.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","50","50.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_UMI","Upper-middle-income","","ZAF","South Africa","","54","54.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2014","2014","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZMB","Zambia","","33","33.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2015","2015","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZMB","Zambia","","47","47.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZMB","Zambia","","58","58.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZMB","Zambia","","64","64.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZMB","Zambia","","65","65.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZMB","Zambia","","66","66.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2016","2016","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZWE","Zimbabwe","","63","63.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2017","2017","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZWE","Zimbabwe","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2018","2018","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZWE","Zimbabwe","","78","78.00000","","","","",""
"MCV2","Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)","https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4756","PUBLISHED","Published","","2019","2019","","AFR","Africa","","WB_LMI","Lower-middle-income","","ZWE","Zimbabwe","","75","75.00000","","","","",""
